Heart failure trials in Mexico

In Mexico 15 Also abroad 1265

15 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2/3Taking people
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
Where
Aguascalientes, Ciudad Madero, Colima, Guadalajara, Hacienda de Las Palmas, León, México, Mexico City, Monterrey
Age
29 days to 17 years
People
342 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT05714085 · EU 2022-501238-52-00
Phase 3Taking people
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Where
Aguascalientes, Culiacán, Juriquilla, Mexico City, Monterrey, Querétaro City
Age
18 years to 99 years
People
5,056 worldwide
Run by
Amgen
See details and how to joinNCT07037459
Phase 3Taking people
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Where
Aguascalientes, Culiacán, Distrito Federal, Guadalajara, Irapuato, México, Monterrey, Tlalnepantla, Torreón
Age
18 years and over
People
6,712 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT06424288 · EU 2023-509706-30-00
Phase 3Taking people
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Where
Aguascalientes, Culiacán, Guadalajara, Irapuato, México, Monterrey, Querétaro, Tijuana, Torreón
Age
18 years and over
People
4,200 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT06935370 · EU 2024-519525-38-00
Phase 3Taking people
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
Where
Ciudad Madero, Guadalajara, Huixquilucan, México D.F., Monterrey, Querétaro, San Luis Potosí City, Tlalpan
Age
Up to 18 years
People
117 worldwide
Run by
Bayer
See details and how to joinNCT07192952 · EU 2024-519830-22-00
Phase 3Taking people
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Where
Acapulco, Aguascalientes, Cuauhtémoc, Cuernavaca, Culiacán, Durango, Guadalajara, Mexico City, Monterrey, Querétaro City, San Juan del Río, Veracruz, Xalapa, Zapopan
Age
40 years and over
People
11,300 worldwide
Run by
AstraZeneca
See details and how to joinNCT06677060 · EU 2024-514506-32-00
No phaseTaking people
The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)
Where
Mexico City
Age
18 years and over
People
754 worldwide
Run by
Sunnybrook Health Sciences Centre
See details and how to joinNCT05427370
Phase 3Taking people
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
Where
Ciudad Madero, Guadalajara, Huixquilucan, Mexico City, Monterrey, Querétaro City, San Luis Potosí City, Tlalpan
Age
6 months to 17 years
People
111 worldwide
Run by
Bayer
See details and how to joinNCT07188805 · EU 2024-519829-38-00
Phase 3Taking people
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Where
Aguascalientes, Chihuahua City, Cuauhtémoc, Culiacán, Guadalajara, Mazatlán, Metepec, México, Mexico City, Monterrey, Morelia, Querétaro, San Luis Potosí City, Tijuana, Torreón, Veracruz, Xalapa
Age
18 years to 130 years
People
3,850 worldwide
Run by
AstraZeneca
See details and how to joinNCT06307652 · EU 2023-508162-15-00
Phase 3Taking people
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
Where
Guadalajara, México, Monterrey, Querétaro, San Luis Potosí City, Tijuana, Xalapa, Zapopan
Age
18 years and over
People
6,950 worldwide
Run by
AstraZeneca
See details and how to joinNCT07761117 · EU 2026-526304-79-00
Phase 3Taking people
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Where
Aguascalientes, Cuauhtémoc, Culiacán, Guadalajara, Mexico City, Monterrey, Morelia, Querétaro, San Nicolás, Xalapa
Age
18 years and over
People
5,200 worldwide
Run by
Colorado Prevention Center
See details and how to joinNCT06008197
No phaseTaking people
iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases
Where
Iztapalapa, León, México, Mexico City
Age
18 years and over
People
35,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT03549754
Phase 3Taking people
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Where
Actopan, Chihuahua City, Ciudad Madero, Col. Roma Norte, Col. Zona Comercial Plaza Del Sol, Cuauhtémoc, Guadalajara, León, Mérida, Monterrey, Oaxaca City, Querétaro City, San Luis Potosí City, San Nicolás de los Garza, Tlalpan, Torreón, Xalapa
Age
18 years and over
People
5,610 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07567001 · EU 2025-523717-29-00
No phaseTaking people
The FILTRATE Trial: High-Rate Ultrafiltration for Intravascular Congestion
Where
Monterrey
Age
18 years and over
People
70
Run by
Universidad Autonoma de Nuevo Leon
See details and how to joinNCT07705269
No phaseNot yet taking people in Mexico
CARTIZ Registry: Cartilage, Arthropathy and Imaging Under Tirzepatide in Zone-stratified Cohorts - A Four-Institute Mexican Observational Registry
Where
Mexico City
Age
18 years and over
People
30
Run by
JULIO GRANADOS MONTIEL
See details and how to joinNCT07567378